Biovica International AB (publ) reported earnings results for the second quarter and six months ended October 31, 2021. For the second quarter, the company reported sales was SEK 0.917 million compared to SEK 0.924 million a year ago. Revenue was SEK 0.991 million compared to SEK 3.57 million a year ago. Net loss was SEK 14.39 million compared to SEK 8.21 million a year ago. Basic loss per share from continuing operations was SEK 0.51 compared to SEK 0.29 a year ago. Diluted loss per share from continuing operations was SEK 0.51 compared to SEK 0.29 a year ago. For the six months, sales was SEK 2.18 million compared to SEK 2.92 million a year ago. Revenue was SEK 2.32 million compared to SEK 5.65 million a year ago. Net loss was SEK 26.61 million compared to SEK 16.58 million a year ago. Basic loss per share from continuing operations was SEK 0.93 compared to SEK 0.59 a year ago. Diluted loss per share from continuing operations was SEK 0.93 compared to SEK 0.59 a year ago.